STAT

Opinion: Smartphones should fuel the next generation of tuberculosis care

I've been working to fight #tuberculosis for 35 years. I'm excited to see sparks of #smartphone innovation for fighting this deadly disease.
Source: Dan Kitwood/Getty Images

For people like me who have devoted their entire medical careers to the fight against tuberculosis, there are finally some reasons to be optimistic about the fight against this scourge. This week, tuberculosis experts from 125 countries are gathering in Amsterdam, surrounded by a buzz of optimism that political leaders will finally come through on their commitments to fight the world’s most deadly infectious disease.

Making progress against tuberculosis hasn’t been easy. Over the 35 years of my professional career, I have seen brilliant people dedicate their lives to reducing the spread of the disease. Yet

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks